Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

A Study of ADVATE in People With Hemophilia A in India

NCT04985682 ·Status: COMPLETED ·Phase: PHASE4

Prophylaxis Versus on Demand Treatment for Children With Hemophilia A

NCT01810666 ·Status: COMPLETED ·Phase: PHASE4

ADVATE Post Authorization Safety Surveillance

NCT00214734 ·Status: COMPLETED

Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A

NCT00916032 ·Status: COMPLETED ·Phase: PHASE4

Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A

NCT02930317 ·Status: UNKNOWN ·Phase: PHASE3

A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

NCT04158934 ·Status: ACTIVE_NOT_RECRUITING

Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A

NCT00289536 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A

NCT06297655 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

NCT02078427 ·Status: COMPLETED

A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A

NCT04565236 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A

NCT03815318 ·Status: COMPLETED ·Phase: PHASE3

Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis

NCT02263066 ·Status: COMPLETED

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

NCT01913405 ·Status: COMPLETED ·Phase: PHASE3

Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)

NCT06864975 ·Status: RECRUITING ·Phase: PHASE4

A Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

NCT03747653 ·Status: UNKNOWN

A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

NCT04953000 ·Status: COMPLETED

Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia

NCT04878731 ·Status: COMPLETED ·Phase: PHASE1

Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients

NCT02622646 ·Status: UNKNOWN

Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for Injection

NCT00952822 ·Status: COMPLETED ·Phase: PHASE1

Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.

NCT04061109 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

NCT01125813 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Hemophilia A Patients With FVIII Inhibitors

NCT04023019 ·Status: RECRUITING

Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients

NCT01712438 ·Status: COMPLETED ·Phase: PHASE3

A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate

NCT04876365 ·Status: COMPLETED

Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products

NCT06738485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3